Skip to content
TrialScanner

NCT05757570

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

Phase 1/Phase 2CompletedVRTXLead

Registry record

Lead sponsor
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Conditions
Idiopathic Thrombocytopenic Purpura; Immune Thrombocytopenia; Warm Autoimmune Hemolytic Anemia; Cold Agglutinin Disease
Primary completion
Aug 12, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05757570 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.